Sign inGet started

Novo A/S

Insider CIK 1388325 · BMTI 10% owner · HTGM 10% owner · APEN 10% owner · INGN 10% owner · TBRA 10% owner · CLCD 10% owner · KALV 10% owner · RETA 10% owner · ANAB 10% owner · IRTC 10% owner · MIST 10% owner · OPHT 10% owner · FLXN 10% owner · ALDR 10% owner · NVRO 10% owner · UTRS 10% owner · ZSPH 10% owner · RARX 10% owner · OTIC 10% owner · AKBA 10% owner · AVLN 10% owner · GRTX 10% owner · CRVS 10% owner · RPHM 10% owner · BOLT 10% owner · CMPI 10% owner · CYT 10% owner · MORF 10% owner · SPRB 10% owner · PRAX 10% owner · INZY 10% owner · EWTX 10% owner · EAR 10% owner · ETTX 10% owner · MIRM 10% owner · MPLT 10% owner · MGX 10% owner · ACLX 10% owner · NKTX 10% owner · ALGS 10% owner · GLTO 10% owner · HRMY 10% owner · IRON 10% owner · VERV 10% owner · IOBT 10% owner · COAG 10% owner

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
COAG Hemab Therapeutics Holding C Conversion deriv2026-05-042026-05-0623,343— $00SEC↗
COAG Hemab Therapeutics Holding C Conversion deriv2026-05-042026-05-0671,866— $00SEC↗
COAG Hemab Therapeutics Holding C Conversion deriv2026-05-042026-05-0662,121— $00SEC↗
COAG Hemab Therapeutics Holding C Conversion deriv2026-05-042026-05-0632,695— $00SEC↗
COAG Hemab Therapeutics Holding C Conversion2026-05-042026-05-064,180,550— $04,180,550SEC↗
AVLN Avalyn Pharma Inc. C Conversion deriv2026-05-012026-05-0512,558,081— $00SEC↗
AVLN Avalyn Pharma Inc. C Conversion deriv2026-05-012026-05-055,587,603— $00SEC↗
AVLN Avalyn Pharma Inc. C Conversion deriv2026-05-012026-05-0518,000,000— $00SEC↗
AVLN Avalyn Pharma Inc. C Conversion deriv2026-05-012026-05-051,986,369— $00SEC↗
AVLN Avalyn Pharma Inc. C Conversion deriv2026-05-012026-05-0525,899,284— $00SEC↗
AVLN Avalyn Pharma Inc. P Buy2026-05-012026-05-05555,555$18.00 $10.00M3,883,289SEC↗
AVLN Avalyn Pharma Inc. C Conversion2026-05-012026-05-053,327,734— $03,327,734SEC↗
MPLT MapLight Therapeutics, Inc C Conversion deriv2025-10-282025-10-3026,191,207— $00SEC↗
MPLT MapLight Therapeutics, Inc C Conversion deriv2025-10-282025-10-3019,734,671— $00SEC↗
MPLT MapLight Therapeutics, Inc C Conversion2025-10-282025-10-302,733,681— $02,733,681SEC↗
MPLT MapLight Therapeutics, Inc P Buy2025-10-282025-10-30952,941$17.00 $16.20M3,686,622SEC↗
IOBT IO Biotech, Inc. S Sale2024-07-262024-07-2623,478$1.31 $30.8K4,354,449SEC↗
IOBT IO Biotech, Inc. S Sale2024-07-252024-07-2651,522$1.33 $68.5K4,377,927SEC↗
IOBT IO Biotech, Inc. S Sale2024-05-102024-05-14658,809$1.22 $803.7K4,429,449SEC↗
SPRB SPRUCE BIOSCIENCES, INC. S Sale2024-03-212024-03-25465,021$0.75 $348.8K2,550,000SEC↗
SPRB SPRUCE BIOSCIENCES, INC. S Sale2024-03-202024-03-20359,979$0.73 $262.8K3,015,021SEC↗
SPRB SPRUCE BIOSCIENCES, INC. S Sale2024-03-192024-03-20593,000$0.76 $450.7K3,375,000SEC↗
SPRB SPRUCE BIOSCIENCES, INC. S Sale2024-03-182024-03-20842,020$0.77 $648.4K3,968,000SEC↗
SPRB SPRUCE BIOSCIENCES, INC. S Sale2024-03-142024-03-181,912,316$0.89 $1.70M4,810,020SEC↗
MGX Metagenomi, Inc. C Conversion deriv2024-02-132024-02-15691,760— $00SEC↗
MGX Metagenomi, Inc. C Conversion deriv2024-02-132024-02-15147,415— $00SEC↗
MGX Metagenomi, Inc. C Conversion2024-02-132024-02-15839,175— $0939,175SEC↗
MGX Metagenomi, Inc. P Buy2024-02-132024-02-15800,000$15.00 $12.00M1,739,175SEC↗
IOBT IO Biotech, Inc. S Sale2024-02-092024-02-13658,809$1.50 $988.2K5,088,258SEC↗
MGX Metagenomi, Inc. P Buy2024-02-092024-02-15100,000$10.25 $1.02M100,000SEC↗
IOBT IO Biotech, Inc. P Buy deriv2023-08-092023-08-112,469,135$2.03 $5.01M2,469,135SEC↗
IOBT IO Biotech, Inc. P Buy2023-08-092023-08-112,469,135$2.03 $5.01M5,707,467SEC↗
CYT Cyteir Therapeutics, Inc. S Sale2023-07-202023-07-20100,000$2.75 $275.0K3,522,136SEC↗
CYT Cyteir Therapeutics, Inc. S Sale2023-07-192023-07-201,900$2.76 $5.2K3,622,136SEC↗
CYT Cyteir Therapeutics, Inc. S Sale2023-07-182023-07-186,500$2.76 $17.9K3,624,036SEC↗
CYT Cyteir Therapeutics, Inc. S Sale2023-07-172023-07-1821,100$2.75 $58.0K3,630,536SEC↗
CYT Cyteir Therapeutics, Inc. S Sale2023-07-142023-07-1811,000$2.74 $30.1K3,651,636SEC↗
CYT Cyteir Therapeutics, Inc. S Sale2023-06-302023-07-03200,937$2.63 $528.5K3,662,636SEC↗
IRON Disc Medicine, Inc. S Sale2023-06-282023-06-281,250,000$46.10 $57.63M1,090,772SEC↗
CYT Cyteir Therapeutics, Inc. S Sale2023-06-272023-06-2831,978$1.77 $56.6K3,863,573SEC↗
CYT Cyteir Therapeutics, Inc. S Sale2023-06-262023-06-288,437$1.79 $15.1K3,895,551SEC↗
RPHM Reneo Pharmaceuticals, Inc S Sale2023-06-232023-06-23100,000$7.10 $710.0K3,330,337SEC↗
CYT Cyteir Therapeutics, Inc. S Sale2023-06-232023-06-233,423$1.88 $6.4K3,903,988SEC↗
CYT Cyteir Therapeutics, Inc. S Sale2023-06-222023-06-235,041$1.94 $9.8K3,907,411SEC↗
CYT Cyteir Therapeutics, Inc. S Sale2023-06-212023-06-234,834$1.99 $9.6K3,912,452SEC↗
CYT Cyteir Therapeutics, Inc. S Sale2023-06-202023-06-20744$2.11 $1.6K3,917,286SEC↗
CYT Cyteir Therapeutics, Inc. S Sale2023-06-162023-06-205,983$2.03 $12.1K3,918,030SEC↗
CYT Cyteir Therapeutics, Inc. S Sale2023-06-152023-06-2010,002$2.03 $20.3K3,924,013SEC↗
CYT Cyteir Therapeutics, Inc. S Sale2023-06-142023-06-142,872$2.11 $6.1K3,934,015SEC↗
CYT Cyteir Therapeutics, Inc. S Sale2023-06-132023-06-142,626$2.10 $5.5K3,936,887SEC↗
CYT Cyteir Therapeutics, Inc. S Sale2023-06-122023-06-14900$2.06 $1.9K3,939,513SEC↗
SPRB SPRUCE BIOSCIENCES, INC. P Buy deriv2023-02-162023-02-211,656,000— $01,656,000SEC↗
SPRB SPRUCE BIOSCIENCES, INC. P Buy2023-02-162023-02-212,208,000$3.17 $7.00M6,722,336SEC↗
EWTX Edgewise Therapeutics, Inc P Buy2022-09-142022-09-16484,496$10.32 $5.00M6,071,703SEC↗
CYT Cyteir Therapeutics, Inc. S Sale2022-07-202022-07-22900,000$3.00 $2.70M3,940,413SEC↗
BOLT Bolt Biotherapeutics, Inc. S Sale2022-07-132022-07-15800,000$2.00 $1.60M3,703,991SEC↗
CMPI Checkmate Pharmaceuticals, S Sale2022-02-252022-02-25300$2.70 $8102,161,990SEC↗
CMPI Checkmate Pharmaceuticals, S Sale2022-02-242022-02-255,990$2.83 $17.0K2,162,290SEC↗
CMPI Checkmate Pharmaceuticals, S Sale2022-02-232022-02-251,820$2.90 $5.3K2,168,280SEC↗
ACLX Arcellx, Inc. C Conversion deriv2022-02-082022-02-09533,389— $00SEC↗
ACLX Arcellx, Inc. C Conversion deriv2022-02-082022-02-09666,651— $00SEC↗
ACLX Arcellx, Inc. C Conversion deriv2022-02-082022-02-09433,196— $00SEC↗
ACLX Arcellx, Inc. C Conversion deriv2022-02-082022-02-091,550,309— $00SEC↗
ACLX Arcellx, Inc. C Conversion2022-02-082022-02-093,183,545— $03,183,545SEC↗
ACLX Arcellx, Inc. P Buy2022-02-082022-02-09833,333$15.00 $12.50M4,016,878SEC↗
IOBT IO Biotech, Inc. C Conversion deriv2021-11-092021-11-1075,267— $00SEC↗
IOBT IO Biotech, Inc. C Conversion deriv2021-11-092021-11-10217,107— $00SEC↗
IOBT IO Biotech, Inc. C Conversion2021-11-092021-11-102,952,932— $02,952,932SEC↗
IOBT IO Biotech, Inc. P Buy2021-11-092021-11-10325,000$14.00 $4.55M3,277,932SEC↗
UTRS MINERVA SURGICAL INC C Conversion deriv2021-10-262021-10-27884,484— $00SEC↗
UTRS MINERVA SURGICAL INC C Conversion deriv2021-10-262021-10-270— $00SEC↗
UTRS MINERVA SURGICAL INC P Buy2021-10-262021-10-27580,000$12.00 $6.96M2,057,132SEC↗
UTRS MINERVA SURGICAL INC C Conversion2021-10-262021-10-27884,484— $0884,484SEC↗
UTRS MINERVA SURGICAL INC C Conversion2021-10-262021-10-27592,648— $01,477,132SEC↗
CYT Cyteir Therapeutics, Inc. C Conversion deriv2021-06-222021-06-2314,000,000— $00SEC↗
CYT Cyteir Therapeutics, Inc. C Conversion deriv2021-06-222021-06-231,553,116— $00SEC↗
CYT Cyteir Therapeutics, Inc. P Buy2021-06-222021-06-23277,777$18.00 $5.00M4,840,413SEC↗
CYT Cyteir Therapeutics, Inc. C Conversion2021-06-222021-06-234,562,636— $04,562,636SEC↗
VERV Verve Therapeutics, Inc. C Conversion deriv2021-06-212021-06-22443,265— $00SEC↗
VERV Verve Therapeutics, Inc. C Conversion2021-06-212021-06-22443,265— $0443,265SEC↗
VERV Verve Therapeutics, Inc. P Buy2021-06-212021-06-22350,000$19.00 $6.65M793,265SEC↗
INGN Inogen Inc S Sale2021-06-022021-06-03680,000$57.32 $38.98M2,079,320SEC↗
SPRB SPRUCE BIOSCIENCES, INC. S Sale2021-05-192021-05-21475,000$13.90 $6.60M4,514,336SEC↗
RPHM Reneo Pharmaceuticals, Inc C Conversion deriv2021-04-132021-04-1412,367,054— $00SEC↗
RPHM Reneo Pharmaceuticals, Inc C Conversion2021-04-132021-04-142,763,711— $02,763,711SEC↗
RPHM Reneo Pharmaceuticals, Inc P Buy2021-04-132021-04-14666,666$15.00 $10.00M3,430,377SEC↗
EWTX Edgewise Therapeutics, Inc C Conversion deriv2021-03-302021-03-311,952,439— $00SEC↗
EWTX Edgewise Therapeutics, Inc C Conversion deriv2021-03-302021-03-31650,328— $00SEC↗
EWTX Edgewise Therapeutics, Inc C Conversion deriv2021-03-302021-03-312,359,440— $00SEC↗
EWTX Edgewise Therapeutics, Inc P Buy2021-03-302021-03-31625,000$16.00 $10.00M5,587,207SEC↗
EWTX Edgewise Therapeutics, Inc C Conversion2021-03-302021-03-314,962,207— $04,962,207SEC↗
INGN Inogen Inc S Sale2021-03-012021-03-03790,000$49.00 $38.71M2,759,320SEC↗
GRTX Galera Therapeutics, Inc. S Sale2021-02-182021-02-19500,000$10.58 $5.29M2,459,021SEC↗
BOLT Bolt Biotherapeutics, Inc. C Conversion deriv2021-02-092021-02-11421,670— $00SEC↗
BOLT Bolt Biotherapeutics, Inc. C Conversion deriv2021-02-092021-02-112,050,758— $00SEC↗
BOLT Bolt Biotherapeutics, Inc. C Conversion deriv2021-02-092021-02-11458,337— $00SEC↗
BOLT Bolt Biotherapeutics, Inc. C Conversion deriv2021-02-092021-02-111,096,323— $00SEC↗
BOLT Bolt Biotherapeutics, Inc. C Conversion2021-02-092021-02-114,027,088— $04,103,991SEC↗
BOLT Bolt Biotherapeutics, Inc. P Buy2021-02-092021-02-11400,000$20.00 $8.00M4,503,991SEC↗
INZY Inozyme Pharma, Inc. S Sale2021-01-282021-02-01375,000$21.00 $7.88M2,194,379SEC↗
GLTO Galecto, Inc. C Conversion deriv2020-11-022020-11-0425,562— $00SEC↗
GLTO Galecto, Inc. C Conversion deriv2020-11-022020-11-04133,991— $00SEC↗
GLTO Galecto, Inc. C Conversion deriv2020-11-022020-11-04194,666— $00SEC↗
GLTO Galecto, Inc. C Conversion deriv2020-11-022020-11-04181,688— $00SEC↗
GLTO Galecto, Inc. C Conversion deriv2020-11-022020-11-0451,911— $00SEC↗
GLTO Galecto, Inc. C Conversion deriv2020-11-022020-11-0466,666— $00SEC↗
GLTO Galecto, Inc. C Conversion deriv2020-11-022020-11-0415,833— $00SEC↗
GLTO Galecto, Inc. C Conversion deriv2020-11-022020-11-0463,333— $00SEC↗
GLTO Galecto, Inc. C Conversion deriv2020-11-022020-11-0498,930— $00SEC↗
GLTO Galecto, Inc. P Buy2020-11-022020-11-04333,333$15.00 $5.00M2,497,791SEC↗
GLTO Galecto, Inc. C Conversion2020-11-022020-11-042,164,458— $02,164,458SEC↗
PRAX Praxis Precision Medicines C Conversion deriv2020-10-202020-10-21551,794— $00SEC↗
PRAX Praxis Precision Medicines C Conversion deriv2020-10-202020-10-214,150,000— $00SEC↗
PRAX Praxis Precision Medicines C Conversion deriv2020-10-202020-10-21171,410— $00SEC↗
PRAX Praxis Precision Medicines C Conversion deriv2020-10-202020-10-21352,734— $00SEC↗
ALGS Aligos Therapeutics, Inc. C Conversion deriv2020-10-202020-10-221,609,493— $00SEC↗
ALGS Aligos Therapeutics, Inc. C Conversion deriv2020-10-202020-10-22241,219— $00SEC↗
ALGS Aligos Therapeutics, Inc. C Conversion deriv2020-10-202020-10-22563,851— $00SEC↗
EAR Eargo, Inc. C Conversion deriv2020-10-202020-10-22737,071— $00SEC↗
PRAX Praxis Precision Medicines C Conversion2020-10-202020-10-212,442,080— $02,442,080SEC↗
ALGS Aligos Therapeutics, Inc. P Buy2020-10-202020-10-22200,000$15.00 $3.00M2,614,563SEC↗
ALGS Aligos Therapeutics, Inc. C Conversion2020-10-202020-10-222,414,563— $02,414,563SEC↗
EAR Eargo, Inc. C Conversion2020-10-202020-10-22737,071— $0737,071SEC↗
EAR Eargo, Inc. P Buy2020-10-202020-10-22150,000$18.00 $2.70M887,071SEC↗
GRTX Galera Therapeutics, Inc. S Sale2020-10-152020-10-19450,000$11.00 $4.95M2,959,021SEC↗
SPRB SPRUCE BIOSCIENCES, INC. C Conversion deriv2020-10-142020-10-1610,000,000— $00SEC↗
SPRB SPRUCE BIOSCIENCES, INC. C Conversion deriv2020-10-142020-10-1621,000,000— $00SEC↗
SPRB SPRUCE BIOSCIENCES, INC. C Conversion2020-10-142020-10-164,739,336— $04,739,336SEC↗
SPRB SPRUCE BIOSCIENCES, INC. P Buy2020-10-142020-10-16250,000$15.00 $3.75M4,989,336SEC↗
HRMY Harmony Biosciences Holdin C Conversion deriv2020-08-212020-08-251,860,107— $00SEC↗
HRMY Harmony Biosciences Holdin C Conversion deriv2020-08-212020-08-2525,000,000— $00SEC↗
HRMY Harmony Biosciences Holdin C Conversion deriv2020-08-212020-09-0425,000,000— $00SEC↗
HRMY Harmony Biosciences Holdin C Conversion deriv2020-08-212020-09-041,860,107— $00SEC↗
HRMY Harmony Biosciences Holdin C Conversion2020-08-212020-08-254,277,300— $04,277,300SEC↗
HRMY Harmony Biosciences Holdin P Buy2020-08-212020-08-25132,503$24.00 $3.18M4,409,803SEC↗
HRMY Harmony Biosciences Holdin C Conversion2020-08-212020-09-043,622,470— $03,754,973SEC↗
CMPI Checkmate Pharmaceuticals, C Conversion deriv2020-08-112020-08-1312,487,512— $00SEC↗
CMPI Checkmate Pharmaceuticals, C Conversion2020-08-112020-08-131,670,100— $01,670,100SEC↗
CMPI Checkmate Pharmaceuticals, P Buy2020-08-112020-08-13500,000$15.00 $7.50M2,170,100SEC↗
INZY Inozyme Pharma, Inc. C Conversion deriv2020-07-282020-07-291,398,600— $00SEC↗
INZY Inozyme Pharma, Inc. C Conversion deriv2020-07-282020-07-2915,000,000— $00SEC↗
INZY Inozyme Pharma, Inc. C Conversion2020-07-282020-07-292,194,379— $02,194,379SEC↗
INZY Inozyme Pharma, Inc. P Buy2020-07-282020-07-29375,000$16.00 $6.00M2,569,379SEC↗
NKTX Nkarta, Inc. C Conversion deriv2020-07-142020-07-16525,499— $00SEC↗
NKTX Nkarta, Inc. C Conversion deriv2020-07-142020-07-161,712,811— $00SEC↗
NKTX Nkarta, Inc. C Conversion2020-07-142020-07-162,238,310— $02,238,310SEC↗
NKTX Nkarta, Inc. P Buy2020-07-142020-07-16555,555$18.00 $10.00M2,793,865SEC↗
CRVS Corvus Pharmaceuticals, In S Sale2020-07-082020-07-09741,440$5.37 $3.98M1,389,498SEC↗
CRVS Corvus Pharmaceuticals, In S Sale2020-07-072020-07-09796,622$5.25 $4.18M2,130,938SEC↗
MIST Milestone Pharmaceuticals S Sale2019-11-252019-11-27240,000$16.00 $3.84M2,434,470SEC↗
GRTX Galera Therapeutics, Inc. C Conversion deriv2019-11-122019-11-142,709,659— $00SEC↗
GRTX Galera Therapeutics, Inc. C Conversion deriv2019-11-122019-11-1412,000,000— $00SEC↗
GRTX Galera Therapeutics, Inc. C Conversion2019-11-122019-11-14535,869— $02,909,021SEC↗
GRTX Galera Therapeutics, Inc. C Conversion2019-11-122019-11-142,373,152— $02,373,152SEC↗
GRTX Galera Therapeutics, Inc. P Buy2019-11-122019-11-14500,000$12.00 $6.00M3,409,021SEC↗
CRVS Corvus Pharmaceuticals, In S Sale2019-07-252019-07-251,400,000$4.00 $5.60M2,927,560SEC↗
CRVS Corvus Pharmaceuticals, In S Sale2019-07-242019-07-2553,240$5.01 $266.7K4,327,560SEC↗
CRVS Corvus Pharmaceuticals, In S Sale2019-07-232019-07-2539,716$5.32 $211.3K4,380,800SEC↗
MIRM Mirum Pharmaceuticals, Inc C Conversion deriv2019-07-222019-07-231,870,147— $00SEC↗
MIRM Mirum Pharmaceuticals, Inc P Buy2019-07-222019-07-23575,000$15.00 $8.63M2,445,147SEC↗
MIRM Mirum Pharmaceuticals, Inc C Conversion2019-07-222019-07-231,870,147— $01,870,147SEC↗
MORF Morphic Holding, Inc. C Conversion deriv2019-06-282019-07-011,978,779— $00SEC↗
MORF Morphic Holding, Inc. C Conversion2019-06-282019-07-011,978,779— $01,978,779SEC↗
MORF Morphic Holding, Inc. P Buy2019-06-282019-07-01666,667$15.00 $10.00M2,645,446SEC↗
MIST Milestone Pharmaceuticals M Exercise deriv2019-05-132019-05-14964,089— $00SEC↗
MIST Milestone Pharmaceuticals M Exercise deriv2019-05-132019-05-141,377,048— $00SEC↗
MIST Milestone Pharmaceuticals P Buy2019-05-132019-05-14333,333$15.00 $5.00M2,674,470SEC↗
MIST Milestone Pharmaceuticals M Exercise2019-05-132019-05-14964,089— $02,341,137SEC↗
MIST Milestone Pharmaceuticals M Exercise2019-05-132019-05-141,377,048— $01,377,048SEC↗
ETTX Entasis Therapeutics Holdi C Conversion deriv2018-09-282018-10-017,000,000— $00SEC↗
ETTX Entasis Therapeutics Holdi C Conversion deriv2018-09-282018-10-0114,237,288— $00SEC↗
ETTX Entasis Therapeutics Holdi P Buy2018-09-282018-10-011,089,835$15.00 $16.35M2,181,843SEC↗
ETTX Entasis Therapeutics Holdi C Conversion2018-09-282018-10-011,092,008— $01,092,008SEC↗
CRVS Corvus Pharmaceuticals, In P Buy2018-03-122018-03-131,176,470$8.50 $10.00M4,420,516SEC↗
KALV KalVista Pharmaceuticals, S Sale2017-10-122017-10-12481$10.02 $4.8K1,726,000SEC↗
KALV KalVista Pharmaceuticals, S Sale2017-10-122017-10-121,726,000$8.50 $14.67M0SEC↗
KALV KalVista Pharmaceuticals, S Sale2017-10-112017-10-1235,519$10.21 $362.6K1,726,481SEC↗
KALV KalVista Pharmaceuticals, S Sale2017-10-102017-10-12165,199$12.32 $2.04M1,955,747SEC↗
KALV KalVista Pharmaceuticals, S Sale2017-10-102017-10-12190,981$11.18 $2.14M2,120,946SEC↗
KALV KalVista Pharmaceuticals, S Sale2017-10-102017-10-12413,356$10.36 $4.28M2,311,927SEC↗
KALV KalVista Pharmaceuticals, S Sale2017-10-102017-10-1261,044$13.39 $817.4K1,894,703SEC↗
KALV KalVista Pharmaceuticals, S Sale2017-10-102017-10-1257,580$14.07 $810.2K1,837,123SEC↗
KALV KalVista Pharmaceuticals, S Sale2017-10-102017-10-1275,123$15.36 $1.15M1,762,000SEC↗
KALV KalVista Pharmaceuticals, S Sale2017-09-152017-09-15140,744$7.00 $985.2K2,725,283SEC↗
KALV KalVista Pharmaceuticals, S Sale2017-09-152017-09-153$8.00 $242,725,280SEC↗
KALV KalVista Pharmaceuticals, S Sale2017-09-152017-09-18140,744$7.00 $985.2K2,725,283SEC↗
KALV KalVista Pharmaceuticals, S Sale2017-09-142017-09-1510,000$8.05 $80.5K2,866,027SEC↗
KALV KalVista Pharmaceuticals, S Sale2017-09-142017-09-1810,000$8.05 $80.5K2,866,027SEC↗
KALV KalVista Pharmaceuticals, S Sale2017-09-132017-09-1525,900$8.02 $207.7K2,876,027SEC↗
KALV KalVista Pharmaceuticals, S Sale2017-09-132017-09-1825,900$8.02 $207.7K2,876,027SEC↗
HTGM HTG MOLECULAR DIAGNOSTICS, S Sale2017-08-252017-08-25720,214$1.75 $1.26M0SEC↗
HTGM HTG MOLECULAR DIAGNOSTICS, S Sale2017-08-242017-08-25382,437$1.91 $730.5K720,214SEC↗
HTGM HTG MOLECULAR DIAGNOSTICS, S Sale2017-08-232017-08-2547,162$2.02 $95.3K1,102,651SEC↗
HTGM HTG MOLECULAR DIAGNOSTICS, S Sale2017-08-222017-08-2212,641$2.01 $25.4K1,199,599SEC↗
ANAB ANAPTYSBIO INC S Sale2017-08-212017-08-21356,300$21.10 $7.52M1,936,604SEC↗
HTGM HTG MOLECULAR DIAGNOSTICS, S Sale2017-08-212017-08-2212,845$2.02 $25.9K1,212,240SEC↗
HTGM HTG MOLECULAR DIAGNOSTICS, S Sale2017-08-182017-08-2255,100$2.10 $115.7K1,225,085SEC↗
ANAB ANAPTYSBIO INC S Sale2017-08-152017-08-16143,428$21.00 $3.01M2,292,904SEC↗
ANAB ANAPTYSBIO INC S Sale2017-08-142017-08-1635,172$21.79 $766.4K2,436,332SEC↗
ANAB ANAPTYSBIO INC S Sale2017-08-072017-08-08480,000$21.10 $10.13M2,472,527SEC↗
ANAB ANAPTYSBIO INC S Sale2017-08-072017-08-081,023$22.92 $23.4K2,471,504SEC↗
ANAB ANAPTYSBIO INC S Sale2017-08-042017-08-0810,271$22.00 $226.0K2,952,527SEC↗
ANAB ANAPTYSBIO INC S Sale2017-08-032017-08-0321,451$22.01 $472.1K2,962,798SEC↗
ANAB ANAPTYSBIO INC S Sale2017-08-022017-08-0325,700$23.87 $613.5K2,984,249SEC↗
ANAB ANAPTYSBIO INC S Sale2017-08-012017-08-0323,555$23.87 $562.3K3,009,949SEC↗
APEN Apollo Endosurgery, Inc. S Sale2017-07-262017-07-268,426$6.84 $57.6K1,301,842SEC↗
APEN Apollo Endosurgery, Inc. S Sale2017-07-252017-07-2624,504$6.96 $170.5K1,310,268SEC↗
APEN Apollo Endosurgery, Inc. S Sale2017-07-242017-07-2617,200$6.83 $117.5K1,334,772SEC↗
CRVS Corvus Pharmaceuticals, In P Buy2017-06-232017-06-2720,000$10.95 $219.0K3,244,046SEC↗
RETA REATA PHARMACEUTICALS INC S Sale deriv2017-06-222017-06-231,200,000$25.00 $30.00M1,201,969SEC↗
RETA REATA PHARMACEUTICALS INC S Sale2017-06-142017-06-1449,611$25.03 $1.24M592,794SEC↗
RETA REATA PHARMACEUTICALS INC S Sale2017-06-132017-06-1411,389$25.47 $290.1K642,405SEC↗
RETA REATA PHARMACEUTICALS INC S Sale2017-06-122017-06-1290,303$25.28 $2.28M653,794SEC↗
RETA REATA PHARMACEUTICALS INC S Sale2017-06-092017-06-122,200$25.89 $57.0K744,097SEC↗
RETA REATA PHARMACEUTICALS INC S Sale2017-06-082017-06-12130,000$26.00 $3.38M746,297SEC↗
RETA REATA PHARMACEUTICALS INC S Sale2017-06-072017-06-072,000$28.04 $56.1K876,297SEC↗
RETA REATA PHARMACEUTICALS INC S Sale2017-06-062017-06-0764,170$28.09 $1.80M878,297SEC↗
RETA REATA PHARMACEUTICALS INC S Sale2017-06-052017-06-0723,327$28.67 $668.8K942,467SEC↗
APEN Apollo Endosurgery, Inc. S Sale2017-05-112017-05-11103,500$5.62 $581.7K1,351,972SEC↗
APEN Apollo Endosurgery, Inc. S Sale2017-05-102017-05-111,500$5.74 $8.6K1,455,472SEC↗
ANAB ANAPTYSBIO INC C Conversion deriv2017-01-312017-02-01486,820— $00SEC↗
ANAB ANAPTYSBIO INC C Conversion deriv2017-01-312017-02-01673,454— $00SEC↗
ANAB ANAPTYSBIO INC C Conversion deriv2017-01-312017-02-011,428,571— $00SEC↗
ANAB ANAPTYSBIO INC C Conversion deriv2017-01-312017-02-01312,986— $00SEC↗
ANAB ANAPTYSBIO INC X Exercise deriv2017-01-312017-02-01117,235— $00SEC↗
ANAB ANAPTYSBIO INC P Buy2017-01-312017-02-0150,000$15.00 $750.0K3,033,504SEC↗
ANAB ANAPTYSBIO INC X Exercise2017-01-312017-02-0181,673— $02,983,504SEC↗
ANAB ANAPTYSBIO INC C Conversion2017-01-312017-02-01673,454— $02,901,831SEC↗
ANAB ANAPTYSBIO INC C Conversion2017-01-312017-02-01312,986— $02,228,377SEC↗
ANAB ANAPTYSBIO INC C Conversion2017-01-312017-02-01486,820— $01,915,391SEC↗
ANAB ANAPTYSBIO INC C Conversion2017-01-312017-02-011,428,571— $01,428,571SEC↗
OPHT Ophthotech Corp. S Sale2016-12-152016-12-161,405,487$4.72 $6.63M0SEC↗
OPHT Ophthotech Corp. S Sale2016-12-142016-12-162,205,000$4.97 $10.96M1,405,487SEC↗
RARX Ra Pharmaceuticals, Inc. C Conversion deriv2016-10-312016-11-02860,438— $00SEC↗
RARX Ra Pharmaceuticals, Inc. C Conversion deriv2016-10-312016-11-02924,970— $00SEC↗
RARX Ra Pharmaceuticals, Inc. C Conversion2016-10-312016-11-02924,970— $0924,970SEC↗
RARX Ra Pharmaceuticals, Inc. C Conversion2016-10-312016-11-02860,438— $01,785,408SEC↗
RARX Ra Pharmaceuticals, Inc. P Buy2016-10-312016-11-02246,154$13.00 $3.20M2,031,562SEC↗
IRTC iRhythm Technologies, Inc. C Conversion deriv2016-10-252016-10-262,007,449— $00SEC↗
IRTC iRhythm Technologies, Inc. C Conversion2016-10-252016-10-262,007,449— $02,024,448SEC↗
IRTC iRhythm Technologies, Inc. P Buy2016-10-252016-10-26100,000$17.00 $1.70M2,124,448SEC↗
CLCD CoLucid Pharmaceuticals, I P Buy2016-09-092016-09-13100,000$20.00 $2.00M3,156,563SEC↗
TBRA Tobira Therapeutics, Inc. S Sale2016-07-132016-07-1329,884$11.88 $355.0K1,875,905SEC↗
TBRA Tobira Therapeutics, Inc. S Sale2016-07-122016-07-138,752$12.12 $106.1K1,905,789SEC↗
TBRA Tobira Therapeutics, Inc. S Sale2016-07-112016-07-1320,431$12.19 $249.1K1,914,541SEC↗
TBRA Tobira Therapeutics, Inc. S Sale2016-07-072016-07-0721,869$12.03 $263.1K1,934,972SEC↗
TBRA Tobira Therapeutics, Inc. S Sale2016-07-062016-07-0759,850$12.20 $730.2K1,956,841SEC↗
TBRA Tobira Therapeutics, Inc. S Sale2016-07-052016-07-0710,400$12.57 $130.7K2,016,691SEC↗
TBRA Tobira Therapeutics, Inc. S Sale2016-06-302016-06-3027,133$12.58 $341.3K2,027,091SEC↗
TBRA Tobira Therapeutics, Inc. S Sale2016-06-292016-06-3016,068$12.63 $202.9K2,054,224SEC↗
TBRA Tobira Therapeutics, Inc. S Sale2016-06-282016-06-3020,883$13.77 $287.6K2,073,022SEC↗
TBRA Tobira Therapeutics, Inc. S Sale2016-06-282016-06-302,730$14.28 $39.0K2,070,292SEC↗
TBRA Tobira Therapeutics, Inc. S Sale2016-06-062016-06-07187,500$10.37 $1.94M2,093,905SEC↗
RETA REATA PHARMACEUTICALS INC C Conversion deriv2016-06-012016-08-05215,794— $02,401,969SEC↗
RETA REATA PHARMACEUTICALS INC C Conversion2016-06-012016-08-05215,794— $0965,794SEC↗
RETA REATA PHARMACEUTICALS INC P Buy2016-06-012016-06-02750,000$11.00 $8.25M750,000SEC↗
OPHT Ophthotech Corp. S Sale2016-05-242016-05-251,300,000$49.00 $63.70M3,610,489SEC↗
CRVS Corvus Pharmaceuticals, In P Buy2016-05-122016-05-1670,000$10.00 $700.0K3,224,046SEC↗
CRVS Corvus Pharmaceuticals, In C Conversion deriv2016-03-292016-03-30356,888— $00SEC↗
CRVS Corvus Pharmaceuticals, In C Conversion deriv2016-03-292016-03-302,130,492— $00SEC↗
CRVS Corvus Pharmaceuticals, In P Buy2016-03-292016-03-30666,666$15.00 $10.00M3,154,046SEC↗
CRVS Corvus Pharmaceuticals, In C Conversion2016-03-292016-03-302,130,492— $02,130,492SEC↗
CRVS Corvus Pharmaceuticals, In C Conversion2016-03-292016-03-30356,888— $02,487,380SEC↗
TBRA Tobira Therapeutics, Inc. S Sale2016-03-042016-03-0455,000$6.54 $359.7K2,281,405SEC↗
TBRA Tobira Therapeutics, Inc. S Sale2016-03-032016-03-0425,000$6.86 $171.5K2,336,405SEC↗
TBRA Tobira Therapeutics, Inc. S Sale2016-03-022016-03-04110,000$6.92 $761.2K2,361,405SEC↗
TBRA Tobira Therapeutics, Inc. S Sale2015-11-182015-11-19153,601$9.76 $1.50M2,471,405SEC↗
TBRA Tobira Therapeutics, Inc. S Sale2015-11-172015-11-1971,399$9.87 $704.7K2,625,006SEC↗
FLXN Flexion Therapeutics Inc S Sale2015-06-222015-06-2263,412$20.55 $1.30M2,133,131SEC↗
FLXN Flexion Therapeutics Inc S Sale2015-06-192015-06-2250,888$20.07 $1.02M2,196,543SEC↗
FLXN Flexion Therapeutics Inc S Sale2015-06-182015-06-2235,700$21.51 $767.9K2,247,431SEC↗
CLCD CoLucid Pharmaceuticals, I C Conversion deriv2015-05-112015-05-121,756,563— $00SEC↗
HTGM HTG MOLECULAR DIAGNOSTICS, C Conversion deriv2015-05-112015-05-12156,123— $00SEC↗
HTGM HTG MOLECULAR DIAGNOSTICS, C Conversion deriv2015-05-112015-05-12110,755— $00SEC↗
HTGM HTG MOLECULAR DIAGNOSTICS, X Exercise deriv2015-05-112015-05-1249,786— $00SEC↗
HTGM HTG MOLECULAR DIAGNOSTICS, C Conversion deriv2015-05-112015-05-12598,415— $00SEC↗
CLCD CoLucid Pharmaceuticals, I P Buy2015-05-112015-05-121,300,000$10.00 $13.00M3,056,563SEC↗
CLCD CoLucid Pharmaceuticals, I C Conversion2015-05-112015-05-121,756,563— $01,756,563SEC↗
HTGM HTG MOLECULAR DIAGNOSTICS, C Conversion2015-05-112015-05-12110,755— $0865,293SEC↗
HTGM HTG MOLECULAR DIAGNOSTICS, X Exercise2015-05-112015-05-1249,786— $0915,079SEC↗
HTGM HTG MOLECULAR DIAGNOSTICS, P Buy2015-05-112015-05-12365,106$14.00 $5.11M1,280,185SEC↗
HTGM HTG MOLECULAR DIAGNOSTICS, C Conversion2015-05-112015-05-12754,538— $0754,538SEC↗
TBRA Tibira Therapeutics, Inc. P Buy2015-05-042015-05-06838,041$10.62 $8.90M2,696,405SEC↗
OPHT Ophthotech Corp. X Exercise deriv2015-03-252015-03-2613,668— $00SEC↗
OPHT Ophthotech Corp. X Exercise2015-03-252015-03-2613,668$0.06 $8204,910,487SEC↗
OPHT Ophthotech Corp. S Sale2015-03-052015-03-091,005,000$51.75 $52.01M4,896,819SEC↗
FLXN Flexion Therapeutics Inc P Buy2014-12-172014-12-18500,000$17.00 $8.50M2,283,131SEC↗
OPHT Ophthotech Corp. S Sale2014-11-132014-11-17995,000$40.20 $40.00M5,901,819SEC↗
NVRO NEVRO CORP C Conversion deriv2014-11-122014-11-131,979,841— $00SEC↗
NVRO NEVRO CORP P Buy2014-11-122014-11-13215,000$18.00 $3.87M2,194,841SEC↗
NVRO NEVRO CORP C Conversion2014-11-122014-11-131,979,841— $01,979,841SEC↗
INGN Inogen Inc S Sale2014-11-042014-11-052,000,000$21.50 $43.00M3,549,320SEC↗
INGN Inogen Inc X Exercise deriv2014-10-152014-10-172,727— $00SEC↗
INGN Inogen Inc X Exercise deriv2014-10-152014-10-1752,018— $00SEC↗
INGN Inogen Inc X Exercise deriv2014-10-152014-10-1711,488— $00SEC↗
INGN Inogen Inc X Exercise deriv2014-10-152014-10-175,570— $00SEC↗
INGN Inogen Inc X Exercise deriv2014-10-152014-10-1726,365— $00SEC↗
INGN Inogen Inc X Exercise deriv2014-10-152014-10-1719,022— $00SEC↗
INGN Inogen Inc X Exercise deriv2014-10-152014-10-1712,681— $00SEC↗
INGN Inogen Inc X Exercise2014-10-152014-10-17129,871$38961.30 $5.06B5,549,320SEC↗